Report #2887274

Received Mar 2, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 77 yrs
State: NC
Recovered: Unknown
Vaccinated: Feb 25, 2026
Onset: Feb 25, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	F4AC3	—

Symptoms (1)

Expired product administered

Symptom narrative

Inadvertent administration of an expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 77-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number F4AC3, expiry date 12-DEC-2025) for prophylaxis. On 25-FEB-2026, the patient received Arexvy. On 25-FEB-2026, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Inadvertent administration of an expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 25-FEB-2026 The batch number was not provided upon follow up with the reporter.